Novel blood test for early biomarkers of preeclampsia and Alzheimer’s disease
Abstract A non-invasive and sensitive blood test has long been a goal for early stage disease diagnosis and treatment for Alzheimer’s disease (AD) and other proteinopathy diseases. We previously reported that preeclampsia (PE), a severe pregnancy complication, is another proteinopathy disorder with...
Guardado en:
Autores principales: | Shibin Cheng, Sayani Banerjee, Lori A. Daiello, Akitoshi Nakashima, Sukanta Jash, Zheping Huang, Jonathan D. Drake, Jan Ernerudh, Goran Berg, James Padbury, Shigeru Saito, Brian R. Ott, Surendra Sharma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a0e8b71cb20e4e69945cd735b39330f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers for prediction and diagnostics of preeclampsia
por: O. V. Radkov, et al.
Publicado: (2018) -
Aggregated transthyretin is specifically packaged into placental nano-vesicles in preeclampsia
por: Mancy Tong, et al.
Publicado: (2017) -
Placenta-derived exosomes: potential biomarkers of preeclampsia
por: Pillay P, et al.
Publicado: (2017) -
Metabolomic biomarkers in serum and urine in women with preeclampsia.
por: Marie Austdal, et al.
Publicado: (2014) -
Vascular Dysfunction in Preeclampsia
por: Megan A. Opichka, et al.
Publicado: (2021)